More than doubled risk of thrombosis, cardiomyopathy and other serious vascular events after vaccinations: another study confirms this
According to data collected by a clinic, the vaccinated Moderna and Pftizer appear to have more than doubled the risk of a serious coronary event ( Acute coronary syndrome or ACS) and this for at least 2 months and a half after the inoculation of the second dose.
The data comes from the surveys of a working group headed by Steven R. Gundry , and disclosed in the journal Circulation. Gives 8 years these doctors test the risk a 5 years of a severe cardiac event (ACS) using the test “PLUS Cardiac” produced by GD Biosciences of Irvine to monitor their patients.
This test clinically measures multiple protein biomarkers and provides a weighted risk score. Scoring is based on changes from normal biomarker levels of multiple proteins , among the various markers also IL-16 ( a proinflammatory cytokine) Soluble phase (an inducer of apoptosis and hepatocyte growth factor) HGF ( which serves as a marker for T cell chemotaxis in epithelium and heart tissue) and others .
Raising these markers above the norm increases the PULS score, therefore the risk within i 5 years of having a severe coronary event, while a decrease in biomarkers below normal decreases the PULS risk score.
In a total of 566 patients having dai 28 to the 97 years, equally divided between males and females, these values have already been measured each 3-6 months during the last few 8 years, but with the advent of COVID mRNA vaccines 19, specifically Moderna and Pfizer, dramatic changes in the PULS score were seen in most patients, unfortunately not for the better.
These patients were seen in preventive cardiology as a routine, and they were always carried out the same PULS test , normally in a period from 2 Everyone 10 weeks after the second vaccine dose.
The results were compared with the results of the previous test normally performed by 3 to the 5 months before the vaccine.
The base IL-16 has increased from 35 = / – 20 above the norm a 82 =/- 75 above the post-vaccine norm;
soluble Fas increased from 22 +/- 15 above the norm a 46 =/- 24 above the post-vaccine norm;
HGF increased from 42 +/- 12 above the norm a 86 +/- post-vaccine;
The increase in the score ( PULSE ) of risk of a serious coronary event ( ACS ) within the 5 years has passed on average from 11% pre-vaccine to 25% after the second dose .
At the moment these changes are persisting for at least 2 months and a half after the second dose of vaccine, but there is still no data on what happens in the following months.
The research team concluded that these mRNA vaccines drastically increase inflammation on the endothelium and the infiltration of T cells into the heart muscle and may explain the’ increased thrombosis, cardiomyopathies and other serious vascular events that were observed in large numbers after inoculation.
Research is available here